Depression News and Research

Latest Depression News and Research

Johns Hopkins to host 5th annual Graphic Medicine Conference

The Johns Hopkins University School of Medicine’s Department of Art as Applied to Medicine is hosting the fifth annual Graphic Medicine Conference, to take place June 26 to June 28 in the Preclinical Teaching Building on the Johns Hopkins medical campus.

17 Jun 2014

Discovery may lead to new treatments for common autoimmune diseases

Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system.

17 Jun 2014

Affordable Care Act to have significant impact on patients with diabetes

The Affordable Care Act (ACA, also known as Obamacare) is dramatically changing health care delivery in the U.S. Specific parts of the new law, which will be phased in through 2020, will have a significant impact on patients with diabetes and prediabetes, as explored in a comprehensive Review article published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

17 Jun 2014

New survey explores impact of chronic fatigue on people with rheumatoid arthritis

The National Rheumatoid Arthritis Society in collaboration with 2020health, a leading health social enterprise think tank, today announces the results from Invisible Disease: RA and Chronic Fatigue 2014, a survey of 1,954 people with Rheumatoid Arthritis (RA), to assess the impact of chronic fatigue on their capability for work, emotional and mental health as well as the overall experience of chronic fatigue caused by their RA.

16 Jun 2014

Growth hormone levels may manifest in signs of aging

The decreased production of growth hormone is caused by a physiological process known as somatopause, which practically affects the entire body, since it's involved in body composition, metabolism, bone mineral density and cardiovascular function.

16 Jun 2014

Researchers develop rapid-acting antidepressants for treatment-resistant depression

UT Southwestern Medical Center researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression.

13 Jun 2014

2 medications equally effective in treating major epileptic brain seizures in children

A recently published clinical study in the Journal of the American Medical Association has answered an urgent question that long puzzled ER pediatricians: Is the drug lorazepam really safer and more effective than diazepam - the U.S. Food and Drug Administration-approved medication as first line therapy most often used by emergency room doctors to control major epileptic seizures in children?

13 Jun 2014

Use of opioid linked to higher levels of dissatisfaction following spine surgery

A new study appearing in the Journal of Bone and Joint Surgery (JBJS) links the use of opioid pain relievers (prescription medications, such as Percocet) to less improvement and higher levels of dissatisfaction following spine surgery.

13 Jun 2014

New study show direct link between depression and medication nonadherence

A new study led by Alan B. Ettinger, M.D., M.B.A., Director of the Epilepsy Center at Neurological Surgery, P.C., has found that many patients who fail to take their antiseizure medications are suffering from depression.

12 Jun 2014

Study supports proposal to screen all men with gout for presence of ED

A new study presented today at the European League Against Rheumatism Annual Congress showed that erectile dysfunction (ED) is present in most men with gout and is frequently severe.

12 Jun 2014

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).

12 Jun 2014

Cogstate announces signing of first contract for Precision Recruitment tool

Cognition technology company Cogstate is pleased to announce the signing of its first contract for Precision Recruitment, a new web-based tool for streamlining patient recruitment for clinical drug trials.

12 Jun 2014

Celgene: OTEZLA phase III study for psoriatic arthritis meets primary endpoint

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced results of additional analyses from the phase III clinical trials of OTEZLA, the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4).

11 Jun 2014

New prescription weight-loss medication combines antidepressant with addiction medication

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval.

11 Jun 2014

AeraMax air purifiers reduce exposure to allergens

The true scale of the allergy epidemic is revealed in the British Airborne Allergy Report commissioned by air purification specialists Fellowes, in association with national charity Allergy UK.

11 Jun 2014

Researchers examine effects of testosterone on women after menopause

Testosterone supplementation for women is a hot topic. A new pharmacokinetics study of a brand of testosterone cream for women approved in Western Australia has been published online in Menopause, the journal of The North American Menopause Society (NAMS).

11 Jun 2014

Most traumatic experiences of killing in combat led to decrease in alcohol abuse

It's no secret that combat experiences are highly stressful and can contribute to instances of post-traumatic stress disorder and depression among soldiers post-deployment.

11 Jun 2014

Climate change have significant negative impacts on health and psychological well-being

Climate change will have significant negative impacts on Americans' health and psychological well-being, due to an increase in the frequency and severity of climate-related natural disasters and other climate-related changes in the environment and weather.

10 Jun 2014

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).

10 Jun 2014

New therapeutic interventions could render addiction into manageable disease

Neuroscientists agree that abuse of drugs hijacks circuits in the brain that are crucial for decision-making, but society as a whole tends to stigmatize addicted people for lacking self-control.

10 Jun 2014

Depression News and Research

Latest Depression News and Research

Johns Hopkins to host 5th annual Graphic Medicine Conference

Discovery may lead to new treatments for common autoimmune diseases

Affordable Care Act to have significant impact on patients with diabetes

New survey explores impact of chronic fatigue on people with rheumatoid arthritis

Growth hormone levels may manifest in signs of aging

Researchers develop rapid-acting antidepressants for treatment-resistant depression

2 medications equally effective in treating major epileptic brain seizures in children

Use of opioid linked to higher levels of dissatisfaction following spine surgery

New study show direct link between depression and medication nonadherence

Study supports proposal to screen all men with gout for presence of ED

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Cogstate announces signing of first contract for Precision Recruitment tool

Celgene: OTEZLA phase III study for psoriatic arthritis meets primary endpoint

New prescription weight-loss medication combines antidepressant with addiction medication

AeraMax air purifiers reduce exposure to allergens

Researchers examine effects of testosterone on women after menopause

Most traumatic experiences of killing in combat led to decrease in alcohol abuse

Climate change have significant negative impacts on health and psychological well-being

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

New therapeutic interventions could render addiction into manageable disease

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Depression News and Research

Latest Depression News and Research

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in